PrimeVax Immuno-Oncology Receives IND Permission from FDA For Use of US Army’s Dengue Virus to Treat Cancer
June 06, 2019 18:00 ET
|
PrimeVax Immuno-Oncology, Inc.
CHICAGO, June 06, 2019 (GLOBE NEWSWIRE) -- PrimeVax Immuno-Oncology, Inc. announced today that the company has received permission for their Investigational New Drug (IND) Application from the FDA...